ARCA biopharma, Inc. 4
4 · ARCA biopharma, Inc. · Filed Feb 21, 2017
Insider Transaction Report
Form 4
Hove Anders D
10% Owner
Transactions
- Award
Stock Option (right to buy)
2017-02-16+10,000→ 10,000 totalExercise: $2.50Exp: 2027-02-15→ Common Stock (10,000 underlying)
Holdings
- 311,272(indirect: By LLC)
Common Stock
- 71,487(indirect: By LLC)
Common Stock
- 767,660(indirect: By Venrock Healthcare Capital Partners II, L.P.)
Common Stock
- 390,912(indirect: By Venrock Healthcare Capital Partners, L.P.)
Common Stock
Footnotes (5)
- [F1]These securities are owned directly by Venrock Healthcare Capital Partners II, L.P. The Reporting Person has a pecuniary interest in Venrock Healthcare Capital Partners II, L.P. The Reporting Person holds no voting or investment interest in these securities, and disclaims beneficial ownership of such shares except to the extent of his pro rata partnership interest therein.
- [F2]These securities are owned directly by VHCP Co-Investment Holdings II, LLC. The Reporting Person has a pecuniary interest in VHCP Co-Investment Holdings II, LLC. The Reporting Person holds no voting or investment interest in these securities, and disclaims beneficial ownership of such shares except to the extent of his pro rata partnership interest therein.
- [F3]These securities are owned directly by Venrock Healthcare Capital Partners, L.P. The Reporting Person has a pecuniary interest in Venrock Healthcare Capital Partners, L.P. The Reporting Person holds no voting or investment interest in these securities, and disclaims beneficial ownership of such shares except to the extent of his pro rata partnership interest therein.
- [F4]These securities are owned directly by VHCP Co-Investment Holdings, LLC. The Reporting Person has a pecuniary interest in VHCP Co-Investment Holdings, LLC. The Reporting Person holds no voting or investment interest in these securities, and disclaims beneficial ownership of such shares except to the extent of his pro rata partnership interest therein.
- [F5]Grant to the Reporting Person of a stock option under the 2013 Amended and Restated Equity Incentive Plan, vesting in 12 equal monthly installments beginning as of February 16, 2017. If the Reporting Person's service as a director of the Issuer terminates in connection with or at any time following a change in control (for whatever reason), then any unexpired options that remain unvested shall become fully vested